Cyclosporin metabolism in human liver microsomes and its inhibition by other drugs.
The metabolism of cyclosporin was studied in human liver microsomes. There was no metabolism in the presence of cytochrome C or carbon monoxide or in the absence of cofactors, suggesting metabolism by cytochrome P-450 enzymes. The metabolism was inhibited by ketoconazole and erythromycin, by the steroids methylprednisolone and oestradiol, and by the calcium antagonists diltiazem, nifedipine, prenylamine and verapamil. These in vitro findings correlate well with previously published clinical reports suggesting that these drugs may inhibit the metabolism of cyclosporin in vivo. Our observations suggest that metabolic interactions between cyclosporin and other drugs in vivo may be predicted in vitro under proper experimental conditions.
Henricsson
S
S
Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
Lindholm
A
A
Aravoglou
M
M
D003524:Cyclosporins / Q000097:blood / Q000378:metabolism*; D004110:Diltiazem / Q000494:pharmacology; D006801:Humans; D007654:Ketoconazole / Q000494:pharmacology; D008862:Microsomes, Liver / Q000378:metabolism*; D013997:Time Factors
D003524:Cyclosporins; D004110:Diltiazem; D007654:Ketoconazole